Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-08-05
1998-10-27
Fonda, Kathleen K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 1, 424 80, A61K 31715
Patent
active
058278346
ABSTRACT:
A method of treating anorectal disease is provided which comprises applying to anorectal tissue in need of such treatment an effective amount of a composition comprising a pharmaceutically acceptable carrier and hyaluronic acid or a pharmaceutically acceptable salt thereof in an amount8 of up to about 10% by weight.
REFERENCES:
patent: 2583096 (1952-01-01), Hididian et al.
patent: 3436454 (1969-04-01), Nouvel
patent: 3887703 (1975-06-01), Manoussos et al.
patent: 4141973 (1979-02-01), Balazs
patent: 4272522 (1981-06-01), Balazs
patent: 4303676 (1981-12-01), Balazs
patent: 4582865 (1986-04-01), Balazs et al.
patent: 4636524 (1987-01-01), Balazs et al.
patent: 4684627 (1987-08-01), LeVeen et al.
patent: 4711780 (1987-12-01), Fahim
patent: 4716224 (1987-12-01), Sakurai et al.
patent: 4725585 (1988-02-01), Wenge et al.
patent: 4736024 (1988-04-01), Della Valle et al.
patent: 4755544 (1988-07-01), Makino et al.
patent: 4795741 (1989-01-01), Leschiner et al.
patent: 4801619 (1989-01-01), Lindblad
patent: 4808576 (1989-02-01), Schultz et al.
patent: 4814176 (1989-03-01), Makino et al.
patent: 4840941 (1989-06-01), Ueno et al.
patent: 4851521 (1989-07-01), della Valle et al.
patent: 4853226 (1989-08-01), Machida et al.
patent: 4937254 (1990-06-01), Sheffield et al.
patent: 4946870 (1990-08-01), Partain, III et al.
patent: 4957744 (1990-09-01), della Valle et al.
patent: 4965353 (1990-10-01), della Valle et al.
patent: 4970298 (1990-11-01), Silver et al.
patent: 5095037 (1992-03-01), Iwamitsu et al.
patent: 5166331 (1992-11-01), della Valle et al.
patent: 5234914 (1993-08-01), Gallina
Goodwin, J.S., Prostaglandin E and Cancer Growth: Potential for Immunotherapy with Prostaglandin Synthesis Inhibitors, Augmentive Agents in Cancer Therapy, Raven Press, New York (1981), pp. 393-415.
Asculai, Dr. S., "Inactivation of Herpes Simplex Viruses by Nonionic Surfactants", Antimicobial Agents and Chemotherapy, Apr. 1978, pp. 686-690.
Sneader, W.E., Chemical Abstracts, vol. 76, No. 10, Possible Mechanism for Action of DMSO on Percutaeous absorption, J. Pharm. Pharmcol, 1971, 23 (Supp).
U.S. application No. 07/338,106, Falk, Filed Apr. 1989.
International Preliminary Examination Report for PCT/CA90/00306 and attachement substitute claims.
Alaverdyan et al., "Effect of hyaluronidase, hyaluronic acid, and some other substancs on postradiational experimental bacteriemia", Bulletin of Experimental Biology & Medicine 1967: 64(9): 967-969.
Balazs et al, "The rheological properties and biological funtion of hyaluronic acid", Chem. and Mol. Biol. of the Intercellular Matrix, vol. 3, 1970, pp. 1241-1253.
Sandra Blakeslee, "Solid cores of tumors keeping out best drugs", Jul. 8, 1989 edition of the Globe and Mail, Toronto, Ontario, p. D4.
Pam Harrison, "Toxic drug tamed but still potent" Ontario Medicine, vol. 8, No. 16 dated Aug. 21, 1989, p. 1.
The Merck Index Eleventh Edition, Centennial Edition, Hyaluronic Acid formulation, pp. 751 and 752, 1989.
Alan R. Liss, Inc., Modulation of Immunity in Cancer Patients by Prostaglandin Antagonists, Immunity to Cancer II, Braun, D.P. et al., 1989, pp. 439-448.
Balezs E.A. et al, "Hyaluronic acid: Its structure and use", Cosmetics & Toiletries, Polymers in Cosmetics 1984; 99: 65-72.
Camber O. et al, "Diffusion of some low molecular weight compounds in sodium hyaluronate", Acta Pharmaceutica Suecica 1985; 22(6): 315-320.
Camber O. et al, "Influence of sodium hyaluronate on the meiotic effect of pilocarpine in rabbits", Current Eye Research 1987: 6(6): 779-784.
Chang S-C, "Prodrug and vehicle approaches to improve the therapeutic index of topically applied timolol in the pigmented rabbit", Dissertation Abstracts International 1988; 49(2): 367-B.
Cravioto R O et al, Effects of Precipitates Formed by Insulin with Hyaluronic Acid and Mucoid from Vitreous Humor in Depressing Blood-Sugar Levels Science (1950); vol. 111: 520-521.
Gieldanowski J et al, "Studies on immunosuppresive and anti-inflammatory effects of adriamycin", Arch. Immunol. Ther. Exp. (1980); 28(3): 439-446.
Hassan, H.G., et al., "Effects of adjuvants to local anaesthetics on their duration", Acta Anaesthesiol Scand 1985; 29: 384-388.
Hurd, E.R., "Immunosuppressive and antiinflammatory properties of cyclophosphamide, azathioprine and methotrexate", Arthritis and Rheumatism (1973 Jan./Feb. ); 16(1): 84-88.
Idson B, "Polymers in skin cosmetics", Cosmetics & Toiletries 1988; 103: 63-68.
Johansson A. et al, "Effects of adjuvants to local anaesthetics on their duration", Acta Anaesthesiol Scand 1985; 29: 736-738.
Kalbhen D.A., "The inhibitory effects of steroidal and non-steroidal antirheumatic drugs on articular cartilage in osteoarthrosis and its counteraction by a biological GAG-peptide complex (Rumalon.RTM.)", Z. Rheumatol (1982): 41: 202-211.
Katsu M. et al., "Significance and clinical use of non-steroid anti-inflammatory drugs as substitutes for steroids in steroid dependence", Nippon Rinsho (1986 Jan.) 26(1): 89-95.
Kreis H et al, "Nonsteroid antiinflammatory agents as a substitute treatment for steroids in ATGAM-treated cadaver kidney recipients" Transplantation (1984 Feb.); 37(2): 139-145.
McIlwraith W, "Current concepts in equine degenerative joint disease", Journal of the Am. Veterinary Medical Assoc. 1982; Feb. 1, vol. 180: 239-250.
Mizushima Y., "Possibility of non-steroid anti-inflammatory drugs as a substitute for steroids-analysis of the present situation and demands for the future", Nippon Rinsho (Jan. 1986); 26(1): 61-65.
Nizolek D.J.H. et al, "Corticosteroid and hyaluronic acid treatments in equine degenerative joint disease: A Review" The Cornell Veterinarian 1981: 71(4): 355-375.
Pigman W et al, "Acide hyaluronique et facteurs de permeabilite tissulaire" Bull. Soc. Chim. Biol. 1963; 45(2-3): 185-202.
Pruett RC, et al, "Hyaluronic acid vitreious substitute", In: Vitreous Surgery and Advances in Fundus Diagnosis and Treatment, H. McKenzie Freeman et al Editors, Appleton-Century-Crofts, 1977: Chapter 55, pp. 433-444.
Reim M et al, "Surgical procedures in the treatment of most severe eye burns" Acta Ophthalmologica 1989-Supplementum 192; 67: 47-54.
Rydell N et al, "Effect of intra-articular injection of hyaluronic acid on the clinical symptons of osteoarthritis and on grandulation tissue formation" Clinical Orthopaedics and Related Research 1971; 80 (Oct.): 25-29.
Saba P et al, "Investigation of antihyperlipemic activity of an association of clofibrate and extractive mucopolysaccharide complex", Current Therapeutic Research 1978; 23(4): 455-463.
Stegmann R et al, "Use of Sodium hyaluronate in sever penetrating ocular trauma" Acta Ophthalmol. 1986; 18: 9-13.
Trabucchi E et al, "Prevention of wound dehiscense in severely obese patients with jejuno-ileal by-pass: the role of hyaluronic acid" Pharmatherapeutica 1988; 5(4): 233-239.
Sertoli P et al., L'acido jaluronico, per uso topico, nella cura della ulcere trofocircolatorie degli arti inferiori (Comunicazioni) Giornale Italiano di Dermatologia 1970; 45(8): 468-471.
Walther M, "The Prevention of Strine Cutis Distansae During Pregnancy", Minerva Ginecologica (1981) vo. 33: 497-499.
Weirich E G et al, "Dermatopharmacology of salicyclic acid. III. Topical contra-inflammatory effects of salicylic acid and othe drugs in animal experiments", Dermatologica (1976); 152(2): 87-99.
International Preliminary Examination Report for PCT/CA90/00306 and attachment of substitute claims, no publication date.
Physician's Desk Reference, 49th Edition, Medical Economics Data Production Company, pp. 1566-1570, 1995.
Goodwin et al (eds.) "The Pharmacological Basis of Therapeutics", MacMillan Publishing Co., Inc., New York, 1975, pp. 325-332 & 1365.
Weigel et al., in "The Biology of Hyaluronan" (Evered et al., eds), CIBA Foundation Symposium 143 held 27-28 Sep., 1988, Published 1989, John Wiley & Sons Ltd. New York, pp. 248-264.
West et al (1989) Exp. Cell Res. 183 :179-196.
Verbeeck, R.K. Rectal Administration of NSAIDs (suppositories), 1992, Inflamm. Dis. Ther. Vo 10, pp. 447-460.
Asculai Samuel S.
Falk Rudolf Edgar
Fonda Kathleen K.
Hughes Ivor M.
Hughes Neil H.
Hyal Pharmaceutical Corporation
Sarkis Marcelo K.
LandOfFree
Method of using hyaluronic acid or its pharmaceutically acceptab does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of using hyaluronic acid or its pharmaceutically acceptab, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using hyaluronic acid or its pharmaceutically acceptab will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1613973